Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
01:41pm, Monday, 03'rd Apr 2023
PacBio's (PACB) product development activities raise optimism about the stock.
Pacific Biosciences (PACB) Stock Jumps 18.7%: Will It Continue to Soar?
10:39am, Monday, 03'rd Apr 2023
Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price in
Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen
01:52pm, Friday, 31'st Mar 2023
Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi
PacBio (PACB) New Revio Workflows to Boost Agricultural Output
03:11pm, Thursday, 30'th Mar 2023
PacBio (PACB), in collaboration with Corteva Agriscience, is likely to enable groundbreaking plant and microbial long-read sequencing workflow on Revio system.
Does Pacific Biosciences (PACB) Have the Potential to Rally 30.15% as Wall Street Analysts Expect?
11:29am, Tuesday, 28'th Mar 2023
The mean of analysts' price targets for Pacific Biosciences (PACB) points to a 30.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement am
PacBio's (PACB) Latest Offering to Enhance Genome Analysis
12:14pm, Wednesday, 15'th Mar 2023
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.
PacBio (PACB) Q4 Earnings Match Estimates, Revenues Top
12:48pm, Friday, 17'th Feb 2023
Despite robust Consumables revenues, PacBio (PACB) witnesses overall soft performance in the fourth quarter.
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Thursday, 16'th Feb 2023
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 3.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. (PACB) Q4 2022 Earnings Call Transcript
06:03pm, Thursday, 16'th Feb 2023
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Todd Friedman - Director, Investor Relations Christian Henry -
Jackson Square Partners Cuts Stake in Pacific Biosciences of California
10:31pm, Friday, 10'th Feb 2023
Fintel reports that Jackson Square Partners has filed a 13G/A form with the SEC disclosing ownership of 15.01MM shares of Pacific Biosciences of California Inc (PACB).
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
11:01am, Friday, 10'th Feb 2023
These cutting-edge biotech companies quickly fell out of favor with investors this week.
Illumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparison
02:12am, Monday, 06'th Feb 2023
The gene sequencing market is ripe for disruption. ILMN suffers from multiple strategic setbacks that will likely impact margins for years.
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update
06:28am, Friday, 27'th Jan 2023 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $14.35B to $11.54B this quarter. Click here for an ongoing analysis of the changes made to its portfolio on a quarterly basis.
Investing in Biotech ETFs
04:56pm, Friday, 20'th Jan 2023 The Motley Fool
Here are the five best biotech ETFs to invest in right now.
Cathie Wood Is Crushing It This Year Thanks To 9 Stocks
08:00am, Friday, 20'th Jan 2023
Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.
